H. Becker

1.1k total citations
46 papers, 807 citations indexed

About

H. Becker is a scholar working on Rheumatology, Immunology and Physiology. According to data from OpenAlex, H. Becker has authored 46 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 17 papers in Immunology and 10 papers in Physiology. Recurrent topics in H. Becker's work include Systemic Lupus Erythematosus Research (13 papers), Salivary Gland Disorders and Functions (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). H. Becker is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Salivary Gland Disorders and Functions (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). H. Becker collaborates with scholars based in Germany, Switzerland and United States. H. Becker's co-authors include P. Willeke, M. Gaubitz, Bernhard Schlüter, Wolfram Domschke, K. Federlin, Heiko Schotte, Martin Oppermann, K. Helmke, Frauke Förger and Matthias Tenbusch and has published in prestigious journals such as PLoS ONE, Annals of the New York Academy of Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

H. Becker

45 papers receiving 780 citations

Peers

Countries citing papers authored by H. Becker

Since Specialization

Citations

This map shows the geographic impact of H. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Becker more than expected).

Fields of papers citing papers by H. Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Becker. The network helps show where H. Becker may publish in the future.

Co-authorship network of co-authors of H. Becker

This figure shows the co-authorship network connecting the top 25 collaborators of H. Becker. A scholar is included among the top collaborators of H. Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Becker. H. Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ansprechen einer Dermatomyositis mit Lungenbeteiligung auf eine Januskinase-Inhibitor-Therapie 2018 ·Zeitschrift für Rheumatologie ·(unknown), Toni Weinhage, (unknown), Boris Buerke, Udo Schneider, Hermann Pavenstädt, H. Becker, Gert Gabriëls	18
2	Liver involvement in ANCA-associated vasculitis 2015 ·Clinical Rheumatology ·P. Willeke, Bernhard Schlüter, (unknown), H. Becker, Heiko Schotte	18
3	Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus 2015 ·Arthritis Research & Therapy ·(unknown), (unknown), (unknown), (unknown), H. Becker, Bernhard Schlüter, Annett M. Jacobi	58
4	Platelet counts as a biomarker in ANCA-associated vasculitis 2015 ·Scandinavian Journal of Rheumatology ·P. Willeke, Philipp Kümpers, B. Schlüter, (unknown), H. Becker, H Schotte	30
5	Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis 2015 ·PLoS ONE ·P. Willeke, B. Schlüter, (unknown), H. Becker, Stefan Reuter, Annett M. Jacobi, H Schotte	8
6	Bewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen 2011 ·Zeitschrift für Rheumatologie ·P. Willeke, H. Becker, Siegfried Wassenberg, Hermann Pavenstädt, Annett M. Jacobi	7
7	Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis 2008 ·Clinical Rheumatology ·H. Becker, P. Willeke, Heiko Schotte, Wolfram Domschke, M. Gaubitz	14
8	The role of interleukin‐10 promoter polymorphisms in primary Sjögren's syndrome 2008 ·Scandinavian Journal of Rheumatology ·P. Willeke, M. Gaubitz, H Schotte, H. Becker, Wolfram Domschke, B. Schlüter	11
9	Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome 2007 ·Arthritis Research & Therapy ·P. Willeke, M. Gaubitz, Heiko Schotte, Christian Maaser, Wolfram Domschke, Bernhard Schlüter, H. Becker	21
10	Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney 2007 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Elangovan Gopal, Nagavedi S. Umapathy, Pamela M. Martin, Sudha Ananth, Jaya P. Gnana‐Prakasam, H. Becker, Carsten A. Wagner, Vadivel Ganapathy, Puttur D. Prasad	82
11	Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to -fodrin antibodies 2006 ·Lara D. Veeken ·P. Willeke, M. Gaubitz, H Schotte, H. Becker, (unknown), Wolfram Domschke, B. Schlüter	22
12	Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides 2006 ·Clinical Rheumatology ·H. Becker, Christian Maaser, (unknown), (unknown), Wolfram Domschke, M. Gaubitz	19
13	Clinical Utility of the Anti‐CCP Assay: Experiences with 700 Patients 2005 ·Annals of the New York Academy of Sciences ·(unknown), H. Becker, Matthias F. Seidel, Heiko Schotte, P. Willeke, (unknown), Bernhard Schlüter, Wolfram Domschke, M. Gaubitz	57
14	Traitements des signes non dopamine-dépendants des syndromes parkinsoniens : évaluation et résultats 2003 ·Revue Neurologique ·Sophie Tardieu, H. Becker, Joëlle Micallef, Olivier Blin	0
15	Fensterweite als dosisrelevanter Faktor bei Hochkontraststrukturen in der CT 1998 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·H. Husstedt, Mathias Prokop, H. Becker	12
16	5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: The impact of personality 1995 ·Behavioural Brain Research ·Juergen Hennig, H. Becker, Petra Netter	18
17	Immune Cell and Cortisol Responses to Physically and Pharmacologically Induced Lowering of Body Core Temperature 1993 ·Neuropsychobiology ·Jürgen Hennig, (unknown), H. Becker, Thomas Rammsayer, Petra Netter	15
18	Coexpression of CD4 and CD8 on mitogen-activated peripheral blood T cells from children with asthma: possible involvement of interleukin 4. 1992 ·PubMed ·U. Schauer, (unknown), (unknown), H. Becker, C. Rieger	2
19	Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity 1990 ·Clinical Immunology and Immunopathology ·H. Becker, (unknown), (unknown), K. Federlin	38
20	Inosiplex enhances the growth of Epstein-Barr nuclear antigen-positive B-cells from patients with rheumatoid arthritis and infectious mononucleosis 1988 ·International Journal of Immunopharmacology ·H. Becker, K. Helmke	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact